高级搜索

纵隔镜检查术在 PET/CT纵隔淋巴结阳性的非小细胞肺癌中的应用

廖日强, 杨学宁, 钟文昭, 聂 强, 董 嵩, 王思云, 吴一龙

廖日强, 杨学宁, 钟文昭, 聂 强, 董 嵩, 王思云, 吴一龙. 纵隔镜检查术在 PET/CT纵隔淋巴结阳性的非小细胞肺癌中的应用[J]. 肿瘤防治研究, 2013, 40(12): 1170-1173. DOI: 10.3971/j.issn.1000-8578.2013.12.014
引用本文: 廖日强, 杨学宁, 钟文昭, 聂 强, 董 嵩, 王思云, 吴一龙. 纵隔镜检查术在 PET/CT纵隔淋巴结阳性的非小细胞肺癌中的应用[J]. 肿瘤防治研究, 2013, 40(12): 1170-1173. DOI: 10.3971/j.issn.1000-8578.2013.12.014
LIAO Riqiang, YANG Xuening, ZHONG Wenzhao, NIE Qiang, DONG Song, WANG Siyun, WU Yilong. Role of Mediastinoscopy in PET/CT Positive Mediastinal Involvement in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1170-1173. DOI: 10.3971/j.issn.1000-8578.2013.12.014
Citation: LIAO Riqiang, YANG Xuening, ZHONG Wenzhao, NIE Qiang, DONG Song, WANG Siyun, WU Yilong. Role of Mediastinoscopy in PET/CT Positive Mediastinal Involvement in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1170-1173. DOI: 10.3971/j.issn.1000-8578.2013.12.014

纵隔镜检查术在 PET/CT纵隔淋巴结阳性的非小细胞肺癌中的应用

详细信息
    作者简介:

    廖日强(1975-),男,博士在读,主治医师,主要从事肺癌外科的综合治疗

    通讯作者:

    吴一龙,E-mail:syylwu@live.cn

  • 中图分类号: R734.2

Role of Mediastinoscopy in PET/CT Positive Mediastinal Involvement in Non-small Cell Lung Cancer

  • 摘要: 目的 探讨纵隔镜检查术在纵隔或肺门淋巴结PET/CT(positron emission tomography-computed tomography)代谢阳性的非小细胞肺癌中(non-small cell lung cancer, NSCLC)的应用价值。 方法 回顾性分析纵隔镜检查术前 PET/CT纵隔或肺门淋巴结异常的NSCLC病例,以病理结果为标准,计算纵隔镜检查术诊断纵隔淋巴结转移的敏感度、特异性、阳性预测值、阴性预测值和准确率以及PET/CT 的假阳性率。结果 2007年4月—2011年12月期间, 73例患者符合条件。纵隔镜检查术诊断纵隔淋巴结转移的敏感度、特异性、阳性预测值、阴性预测值和准确率分别为91.3%、100%、100%、87.1%和94.5%。 PET/CT诊断纵隔淋巴结转移的假阳性率高达30.8%。如果将非巨块型纵隔淋巴结代谢升高且双侧肺门淋巴结代谢升高定义为纵隔淋巴结阴性,其阳性预测值升高至81.1%。结论 在 PET/CT纵隔或者肺门淋巴结代谢升高的NSCLC,纵隔镜检查术诊断纵隔淋巴结转移的敏感度和特异性高。对PET/CT代谢阳性的纵隔淋巴结需要病理确认,特别是合并双侧肺门对侧性代谢增高的纵隔淋巴结。

     

    Abstract: Objective To evaluate the value of mediastinoscopy in cases of positive mediastinal/hilar lymph node involvement in positron emission tomography and computed tomography(PET/CT)scanning in nonsmall cell lung cancer. Methods NSCLC cases with mediastinal or hilar involvement in PET/CT treated by mediastinoscopy were retrospectively analyzed. The sensitivity, specifi city, positive predictive value (PPV), negative predictive value (NPV) and accuracy rate of PET/CT and the false positivity of mediastinoscopy in mediastinal staging were calculated. Results Between Apr 2007 and Dec 2011, 73 NSCLC cases were enrolled. The sensitivity, specifi city, PPV, NPV and accuracy rate of mediastinoscopy in mediastinal staging were 91.3%,100%,100%,87.1% and 94.5%,respectively . The the false positivity of PET/CT was 30.8%. If non-bulky mediatinal lymph nodes with bilateral hilar distribution were considered benign, PPV of PET/CT was increased to 81.1%. Conclusion Mediastinoscopy has high sensitivity, specifi city in mediastinal staging in NSCLC cases with mediastinal or hilar involvement in PET/CT. Positive mediastinal involvement in PET/CT, especially bilateral hilar distribution needs to stage by invasive methods.

     

  • [1] De Leyn P, Lardinois D, Van Schil PE,et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer[J]. Eur J Cardiothorac Surg, 2007,32(1):1-8.
    [2] Zhi XY,Wu YL, Bu H,et al. Chinese guidelines on the diagnosis and treatment of primary lung cancer[J]. J Thorac Dis, 20 12,4(1):88-101.
    [3] Wu YL,Huang ZF,Rong TH. Mediastinoscopy for clinical undifferentiated thoracic disease [J]. Zhongguo Xiong Xin Xue Guan Wai Ke Za Zhi, 1998,14(1):28-30. [吴一龙,黄植蕃,戎 铁华.胸部疑难疾病的纵隔镜检查[J]. 中华胸心血管外科杂 志,1998,14(1):28-30.]
    [4] Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) [J]. Chest,2007,132(3 Suppl):202S-220S.
    [5] Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) [J]. Chest,2007,132(3 Suppl):178S-201S.
    [6] Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography [J]. N Engl J Med, 2003,348(25):2500-7.
    [7] Lv YL, Yuan DM, Wang K, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis [J]. J Thorac Oncol, 2011, 6(8):1350-8.
    [8] Wang SX. PET/CT for N2 staging in non-small cell lung cancer [J] Zhongguo Fei Ai Za Zhi, 2008,11(5):646-8. [王淑侠. 非 小细胞肺癌N2无创分期:PET/CT分期[ J ] .中国肺癌杂 志,2008,11(5):646-8. ]
    [9] Darling GE,Maziak DE,Inculet RI, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial [J]. J Thorac Oncol, 2011,6(8):1367-72.
    [10] Tasci E, Tezel C, Orki A, et al. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer [J]. Interact Cardiovasc Thorac Surg, 2010,10(2):200-3.
    [11] Lee JW, Kim BS, Lee DS, et al. 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity [J]. Eur J Nucl Med Mol Imaging, 2009, 36(11):1794-802.
    [12] Gdeedo A, Van Schil P, Corthouts B, et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging[J]. Eur Respir J,1997, 10(7):1547-51.
    [13] Hammoud ZT,Anderson RC,Meyers BF,et al.The current role of mediastinoscopy in the evaluation of thoracic disease[J]. J Thorac Cardiovasc Surg, 1999, 118(5):894-9.
    [14] Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate [J]. Ann Thorac Surg, 2006, 82(4):1185-9.
    [15] Ernst A,Anantham D,Eberhardt,et al.Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy [J]. J Thorac Oncol, 2008, 3( 6):577-82.
    [16] Liao RQ, Yang XN, Wang BC, et al. Diagnosis and staging of mediastinal lymphadenopathy: EBUS-TBNA versus mediastinoscopy[J]. Zhongguo Zhong Liu Lin Chuang,2011, 38 (24):1501-4. [廖日强,杨学宁,汪斌超,等. EBUS-TBNA和纵隔 镜检查术在纵隔淋巴结诊断与分期中的对照研究[J].中国肿瘤 临床,2011,38(24):1501-4.]
    [17] Shrager JB. Mediastinoscopy: still the gold standard[J]. Ann of Thorac Surg, 2010, 89(6):S2084-9.
    [18] Van Schil PE, De Waele M. A second mediastinoscopy: how to decide and how to do it? [J]. Euro J of Cardiothorac Surg, 2008, 33 (4):703-6.
计量
  • 文章访问数:  1512
  • HTML全文浏览量:  30
  • PDF下载量:  642
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-08-22
  • 修回日期:  2012-11-11
  • 刊出日期:  2013-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭